Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

Presenter: Chih-Fan Yeh

October 28, 2025

Presentation TCT 2025

TCT 1423: Transcatheter Rescue in the Setting of Endocarditis: Emergency-Use JenaValve in a Non-Surgical Candidate

Presenter: Ankit Gauba

October 28, 2025

Presentation NY Valves 2025

The Effect of Transcatheter Aortic Valve Replacement With JenaValve Trilogy on 1-Year Reverse Remodeling in Patients With Pure Aortic Regurgitation Stratified by Baseline LV Function

Presenter: Lauren Sharan Ranard

June 27, 2025

Presentation NY Valves 2025

The JenaValve TAVR System: Lessons Learned from the Continued Access Study

Presenter: Raj Makkar

June 26, 2025

Presentation NY Valves 2025

Use of JenaValve in a Young Female With Severe Aortic Regurgitation and Takayasu Arteritis

Presenter: Ankit Gauba

June 25, 2025

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Presenter: Raj Makkar

October 28, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

JenaValve

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

JenaValve Following Previous Ross Procedure

Presenter: Daniel Zumerkorn Hassan

June 06, 2024

Presentation TCT 2023

TCT 288: Implantation Depth and Need for Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement with the JenaValve System in Patients with Severe Aortic Regurgitation

Presenter: Matti Adam

October 25, 2023

Presentation TCT 2023

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Presenter: Vinod Thourani

October 24, 2023

Presentation TVT 2023

Left Ventricular Remodeling after JenaValve Trilogy Transcatheter Aortic Valve Replacement in Patients with Pure Aortic Regurgitation

Presenter: Lauren Ranard

June 09, 2023

Presentation TVT 2023

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

Presenter: Eberhard Grube

June 08, 2023

Presentation TVT 2023

JenaValve

Presenter: Matti Adam

June 08, 2023

Presentation TCT 2022

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

Presenter: Alexander R. Tamm

September 18, 2022

The Dedicated JenaValve TAVR System for AI: Early EU and US Experiences

Presentation TCT 2022

The Dedicated JenaValve TAVR System for AI: Early EU Experience

Presenter: Alexander Tamm

September 18, 2022

Presentation TCT 2022

TCT 678: Jenavalve Trilogy TAVR for severe aortic regurgitation in patient with osteogenesis imperfecta, ascending aneurysm, and severe thoracic tortuosity

Presenter: Stanley Chetcuti

September 17, 2022

Presentation TCT 2022

TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock

Presenter: Lauren Ranard

September 17, 2022

Advertisement

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

TCT 1423: Transcatheter Rescue in the Setting of Endocarditis: Emergency-Use JenaValve in a Non-Surgical Candidate

The Effect of Transcatheter Aortic Valve Replacement With JenaValve Trilogy on 1-Year Reverse Remodeling in Patients With Pure Aortic Regurgitation Stratified by Baseline LV Function

The JenaValve TAVR System: Lessons Learned from the Continued Access Study

Use of JenaValve in a Young Female With Severe Aortic Regurgitation and Takayasu Arteritis

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

JenaValve

JenaValve Following Previous Ross Procedure

TCT 288: Implantation Depth and Need for Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement with the JenaValve System in Patients with Severe Aortic Regurgitation

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Left Ventricular Remodeling after JenaValve Trilogy Transcatheter Aortic Valve Replacement in Patients with Pure Aortic Regurgitation

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

JenaValve

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

The Dedicated JenaValve TAVR System for AI: Early EU Experience

TCT 678: Jenavalve Trilogy TAVR for severe aortic regurgitation in patient with osteogenesis imperfecta, ascending aneurysm, and severe thoracic tortuosity

TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content